PR NEWSWIRE (EN)
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
14 April 2026, 10:50 pm
Telix Successfully Prices and Upsizes US$600 Million Convertible Bonds
14 April 2026, 10:35 pm
Fortune expands Asia leadership with new Editorial Directors and Brand Studio head
14 April 2026, 10:01 pm
Mexican company Farmacias Similares brings Dr. Simi to Tokyo in Japan debut
14 April 2026, 10:00 pm
Zetrix, CAICT’s Astron Unveil Blockchain-AI Trust Layer for Agentic AI Ecosystem
14 April 2026, 7:30 pm
